Cozzi-Lepri Alessandro相关文献与解析，生知库

Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation

病毒学抑制的 HIV 感染者改用双药方案与继续使用三药方案相比，发生临床事件的风险：一项目标试验模拟研究

doi:10.1016/j.eclinm.2025.103368

Mussini, Cristina; Giacomelli, Andrea; Quiros-Roldan, Eugenia; Mazzotta, Valentina; Di Biagio, Antonio; De Vito, Andrea; Costantini, Andrea; D'Ettorre, Gabriella; Giacometti, Andrea; Vergori, Alessandra; Tavelli, Alessandro; Malagnino, Vincenzo; Castagna, Antonella; Chester, Johanna; Antinori, Andrea; d'Arminio Monforte, Antonella; Cozzi-Lepri, Alessandro

Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project

疫情期间因 COVID-19 住院的成年患者的细菌和病毒合并感染：EuCARE 项目的一项多国队列研究

期刊:Journal of Infectious Diseases

影响因子:4.5

doi:10.1093/infdis/jiaf167

Hedberg, Pontus; Serwin, Karol; Francesca Greco, Maria; P V Pereira, Joana; Juozapaite, Dovile; De Benedittis, Sara; Bai, Francesca; Lübke, Nadine; Wienemann, Tobias; Fanti, Iuri; König, Florian; Pfeifer, Nico; Kaiser, Rolf; Zazzi, Maurizio; Cozzi-Lepri, Alessandro; Naumovas, Daniel; Marchetti, Giulia; Parczewski, Milosz; Jensen, Björn-Erik Ole; Incardona, Francesca; Sönnerborg, Anders; Nauclér, Pontus

CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease

一项随机试验比较了门诊重症 COVID-19 高风险人群早期治疗方案的 CT 变化

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-15641-1

Mastrorosa, Ilaria; Cozzi-Lepri, Alessandro; Matusali, Giulia; Colavita, Francesca; Lanini, Simone; Rueca, Martina; Oliva, Alessandra; Berno, Giulia; Vergori, Alessandra; Rosati, Silvia; Paulicelli, Jessica; Girardi, Enrico; Nicastri, Emanuele; Maggi, Fabrizio; Antinori, Andrea; Mazzotta, Valentina

发表日期：2025

文献求助收藏

Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine

HIV感染者接种基于蛋白质或mRNA的XBB.1.5 SARS-CoV-2加强疫苗后，针对近期Omicron亚系的免疫反应

期刊:International Journal of Molecular Sciences

影响因子:

doi:10.3390/ijms26083521

Vergori, Alessandra; Matusali, Giulia; Cimini, Eleonora; Cozzi Lepri, Alessandro; Mazzotta, Valentina; Mariotti, Davide; Colavita, Francesca; Gili, Simona; Cristofanelli, Flavia; Fusto, Marisa; Gagliardini, Roberta; Paulicelli, Jessica; Cecilia, Federico; Girardi, Enrico; Maggi, Fabrizio; Antinori, Andrea

Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort

HIV感染者在接受双联疗法后改用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺的安全性和有效性：来自Icona队列研究的启示

期刊:Hiv Medicine

影响因子:

doi:10.1111/hiv.70037

De Vito, Andrea; Tavelli, Alessandro; Cozzi-Lepri, Alessandro; Giacomelli, Andrea; Rossotti, Roberto; Ponta, Giacomo; Bobbio, Nicoletta; Ianniello, Alice; Cingolani, Antonella; Madeddu, Giordano; Antinori, Andrea; d'Arminio Monforte, Antonella

Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy

意大利一项回顾性分析：特定合并症与HIV-RNA检测不到的HIV感染者抗逆转录病毒疗法转换概率的关系

期刊:Journal of Antimicrobial Chemotherapy

影响因子:

doi:10.1093/jac/dkaf137

Cozzi-Lepri, Alessandro; Tavelli, Alessandro; Taramasso, Lucia; Lapadula, Giuseppe; Bobbio, Nicoletta; Piconi, Stefania; Guaraldi, Giovanni; Di Biagio, Antonio; Castagna, Antonella; Mazzotta, Valentina; d'Arminio Monforte, Antonella

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort

拉米夫定/多替拉韦一线抗逆转录病毒疗法在 HIV 感染者中的疗效：来自 ICONA 基金会队列的真实世界数据

期刊:Journal of Antimicrobial Chemotherapy

影响因子:

doi:10.1093/jac/dkaf345

Vergori, Alessandra; Cozzi-Lepri, Alessandro; Lo Caputo, Sergio; Tavelli, Alessandro; Mazzotta, Valentina; Schiaroli, Elisabetta; Orofino, Giancarlo; Mussini, Cristina; Nozza, Silvia; Cingolani, Antonella; Antinori, Andrea; d'Arminio Monforte, Antonella

Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy)

导致艾滋病毒感染者不接种SARS-CoV-2疫苗加强针的决定因素：一项基于罗马（意大利）行为和流行病学调查的观察性研究

期刊:Human Vaccines & Immunotherapeutics

影响因子:

doi:10.1080/21645515.2025.2582964

Del Duca, Giulia; Sperduti, Isabella; Cozzi Lepri, Alessandro; Mazzotta, Valentina; Drobniewski, Francis; Gagliardini, Roberta; Fusto, Marisa; Plazzi, Maria Maddalena; Paulicelli, Jessica; Vergori, Alessandra; De Ponte, Chiara; Faccendini, Paolo; Gallì, Paola; Girardi, Enrico; Antinori, Andrea

In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project

野生型、α、δ 和 omicron SARS-CoV-2 疫情期间的院内死亡率：EuCARE 项目的一项多国队列研究

期刊:Lancet Regional Health-Europe

影响因子:13

doi:10.1016/j.lanepe.2024.100855

Hedberg, Pontus; Parczewski, Milosz; Serwin, Karol; Marchetti, Giulia; Bai, Francesca; Ole Jensen, Björn-Erik; Pereira, Joana P V; Drobniewski, Francis; Reschreiter, Henrik; Naumovas, Daniel; Ceccherini-Silberstein, Francesca; Rubio Quintanares, Gibran Horemheb; Mwau, Matilu; Toscano, Cristina; König, Florian; Pfeifer, Nico; Zazzi, Maurizio; Fanti, Iuri; Incardona, Francesca; Cozzi-Lepri, Alessandro; Sönnerborg, Anders; Nauclér, Pontus

SARS-CoV-2

发表日期：2024

文献求助收藏

Mortality risk for healthcare workers and journalists in the Gaza Strip over 2023-24

2023-2024年加沙地带医护人员和记者的死亡风险

Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation

病毒学抑制的 HIV 感染者改用双药方案与继续使用三药方案相比，发生临床事件的风险：一项目标试验模拟研究

Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project

疫情期间因 COVID-19 住院的成年患者的细菌和病毒合并感染：EuCARE 项目的一项多国队列研究

CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease

一项随机试验比较了门诊重症 COVID-19 高风险人群早期治疗方案的 CT 变化

Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine

HIV感染者接种基于蛋白质或mRNA的XBB.1.5 SARS-CoV-2加强疫苗后，针对近期Omicron亚系的免疫反应

Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort

HIV感染者在接受双联疗法后改用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺的安全性和有效性：来自Icona队列研究的启示

Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy

意大利一项回顾性分析：特定合并症与HIV-RNA检测不到的HIV感染者抗逆转录病毒疗法转换概率的关系

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort

拉米夫定/多替拉韦一线抗逆转录病毒疗法在 HIV 感染者中的疗效：来自 ICONA 基金会队列的真实世界数据

Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy)

导致艾滋病毒感染者不接种SARS-CoV-2疫苗加强针的决定因素：一项基于罗马（意大利）行为和流行病学调查的观察性研究

In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project

野生型、α、δ 和 omicron SARS-CoV-2 疫情期间的院内死亡率：EuCARE 项目的一项多国队列研究